{"public_metrics": {"retweet_count": 2, "reply_count": 1, "like_count": 28, "quote_count": 1}, "entities": {"mentions": [{"start": 0, "end": 8, "username": "SecAzar", "id": "956283913835614208"}], "annotations": [{"start": 72, "end": 81, "probability": 0.3662, "type": "Organization", "normalized_text": "Remdesivir"}, {"start": 191, "end": 197, "probability": 0.6527, "type": "Organization", "normalized_text": "US Govt"}], "hashtags": [{"start": 237, "end": 245, "tag": "COVID19"}]}, "in_reply_to_user_id": "956283913835614208", "text": "@SecAzar Seems that the manufacturing price of a course of treatment of Remdesivir (sp?) is about $10.\nY'all agreed to $3200 ($2300 for CMS).\n\nAnd the development of it was subsidized by the US Govt.\n\nI'm sure there is no quid pro quo.\n\n#COVID19", "reply_settings": "everyone", "created_at": "2020-06-30T05:12:25.000Z", "source": "Twitter for Android", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1219057585707315201", "name": "COVID-19: Latest news updates from around the world", "description": "This page is a timeline of Tweets with the latest information and updates on COVID-19 from experts, journalists, health authorities and other trusted sources from around the world. For more on COVID-19, visit: twitter.com/explore/tabs/covid-19"}}], "author_id": "975527902052728832", "referenced_tweets": [{"type": "replied_to", "id": "1277608074925219840"}], "id": "1277832338752192512", "lang": "en", "possibly_sensitive": false, "conversation_id": "1277608074925219840"}